Achilles Therapeutics reports Q3 EPS (48c) vs. (42c) last year
Following the discontinuation of its TIL-based cNeT program and closure of the Phase I/IIa CHIRON and THETIS clinical trials, the Company has ...
Achilles Therapeutics PLC: Achilles Therapeutics Reports Third Quarter 2024 Financial Results
Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 - LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics ...
Artnet news3d
Study for Achilles and Thetis
20 x 17 cm. (7.9 x 6.7 in.) ...
manilatimes1d
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced its financial results for ...
Genetic platform identifies 'Achilles heel' of drug-resistant Mycobacterium tuberculosis
A University of Otago-led study has found a highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering ...
BMJ4d
Can ultrasound imaging predict the development of Achilles and patellar tendinopathy? A systematic review and meta-analysis
It is not clear whether the presence of structural abnormalities in asymptomatic tendons predicts the development of future tendon symptoms in the Achilles or patellar tendon. Aim To perform a ...
Nature3d
News & Views
A genetic regulator of tomato sweetness has been identified through comparison of wild and domesticated varieties of the plant. Genetically engineering tomatoes to alter this gene increases sugar ...